A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Aflibercept-Ayyh (PAVBLU)

Aflibercept-Ayyh blocks blood vessel growth to treat cancer or retinal diseases.

First FDA approval2024-10-28
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Aflibercept-Ayyh used for?

Aflibercept-Ayyh blocks blood vessel growth to treat cancer or retinal diseases.

Is there a generic for Aflibercept-Ayyh?

No. Aflibercept-Ayyh is brand-only with no generic equivalents currently in market.

How much does my plan pay for Aflibercept-Ayyh?

NADAC pricing data not currently available for this drug.

Is Aflibercept-Ayyh on the FDA shortage list?

No. Aflibercept-Ayyh is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Vascular Endothelial Growth Factor Inhibitor6 alternatives in D1
01
Aflibercept
Brand: EYDENZELT
Lowest NADAC
0Generic mfrs
$111.8MCY24 Part D spend
Compare →
02
Bevacizumab
Brand: Avastin
Lowest NADAC
0Generic mfrs
$13.1MCY24 Part D spend
Compare →
03
Bevacizumab-Adcd
Brand: Vegzelma
Lowest NADAC
0Generic mfrs
$1.5MCY24 Part D spend
Compare →
04
Bevacizumab-Awwb
Brand: MVASI
Lowest NADAC
0Generic mfrs
$26.0MCY24 Part D spend
Compare →
05
Bevacizumab-Bvzr
Brand: Zirabev
Lowest NADAC
0Generic mfrs
$15.6MCY24 Part D spend
Compare →
06
Bevacizumab-Maly
Brand: ALYMSYS
Lowest NADAC
0Generic mfrs
$5.0MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.